Larvol Delta - EI1071202-A-Phase-2-Study-to-Assess-the-Safety-of-EI1071-and-the-Effects-of-EI1071-on-Neuroinflammation-in-Alzheimer39s-Disease-Patients

enrupatinib (EI-1071) - Elixiron Immunotherap

http://clinicaltrials.gov/ct2/show/NCT06745583

Apr 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next